Workflow
VTR(300381)
icon
Search documents
溢多利:截至2026年1月30日股东人数为20053户
Zheng Quan Ri Bao· 2026-02-02 12:16
Group 1 - The company Yiduoli reported that as of January 30, 2026, the number of shareholders reached 20,053 [2]
溢多利:过氧化氢通常可与硫酸、盐酸等化学品按比例混合配制成高效清洗液
Group 1 - The core viewpoint of the article highlights the application of hydrogen peroxide in creating efficient cleaning solutions for electronic components, specifically for removing organic substances, particles, and metal ions from surfaces [1] - Hydrogen peroxide can be mixed with chemicals like sulfuric acid and hydrochloric acid to formulate these cleaning solutions [1] - The enzyme associated with hydrogen peroxide effectively decomposes residual hydrogen peroxide on component surfaces, preventing adverse effects on subsequent processes and ensuring that wastewater is treated to meet environmental discharge standards by breaking down hydrogen peroxide into water and oxygen [1]
溢多利(300381.SZ)预计2025年度净亏1300万元-2600万元 同比盈转亏
Ge Long Hui A P P· 2026-01-28 14:12
Core Viewpoint - The company Yiduoli (300381.SZ) forecasts a significant decline in net profit for the year 2025, projecting a loss of between 26 million to 13 million yuan, compared to a profit of 31.09 million yuan in the same period last year [1] Group 1: Financial Performance - The expected net profit attributable to shareholders for 2025 is projected to be between -26 million to -13 million yuan, a stark contrast to the previous year's profit of 31.09 million yuan [1] - The anticipated net profit after deducting non-recurring gains and losses is expected to be between -20 million to -10 million yuan, compared to a profit of 5.98 million yuan in the previous year [1] Group 2: Reasons for Performance Change - The company cites insufficient demand in its downstream industry as a reason for increased sales expenses aimed at maintaining existing customers and promoting new products [1] - There has been a reduction in financial investment income and interest income, alongside losses from changes in the fair value of trading financial assets [1] - The company has also reported asset impairment losses from subsidiaries and fixed asset write-off losses at the parent company [1] - The impact of non-recurring gains and losses on the net profit attributable to shareholders is estimated to be around -4 million yuan, primarily due to government subsidies, fixed asset write-off losses, and changes in the fair value of trading financial assets [1]
溢多利:2025年度业绩预告
Zheng Quan Ri Bao· 2026-01-28 13:40
Core Viewpoint - The company Yiduoli has announced a significant expected decline in net profit for the fiscal year 2025, projecting a loss compared to the previous year's profit [2]. Financial Performance - The company expects a net profit attributable to shareholders of between -26 million to -13 million yuan for 2025, a stark contrast to the previous year's profit of 31.09 million yuan [2]. - The net profit after excluding non-recurring gains and losses is projected to be between -20 million to -10 million yuan, compared to 5.98 million yuan in the same period last year [2].
溢多利:预计2025年全年净亏损1300万元—2600万元
Core Viewpoint - The company, Yiduoli, has released an annual performance forecast indicating a significant expected net loss for 2025, attributed to various operational challenges and financial losses [1] Financial Performance - The forecasted net profit attributable to shareholders for 2025 is expected to be between -26 million and -13 million yuan [1] - The forecasted net profit excluding non-recurring gains and losses is expected to be between -20 million and -10 million yuan [1] Reasons for Performance Change - Insufficient demand in the downstream industry has led to increased sales expenses as the company aims to maintain existing customers and promote new products [1] - Decreased financial investment income and interest income, along with losses from changes in the fair value of trading financial assets, have negatively impacted financial performance [1] - The company has recognized asset impairment losses from subsidiaries and incurred fixed asset disposal losses at the parent company [1] Impact of Non-Recurring Gains and Losses - Non-recurring gains and losses are expected to impact the net profit attributable to shareholders by approximately -4 million yuan, primarily due to government subsidies, fixed asset disposal losses, and changes in the fair value of trading financial assets [1]
溢多利:预计2025年净利润为负,预计区间为-2600万元至-1300万元
Xin Lang Cai Jing· 2026-01-28 11:09
Core Viewpoint - The company, Yiduoli, anticipates a negative net profit for the fiscal year 2025, projecting a range between -26 million and -13 million yuan, compared to a profit of 31.09 million yuan in the same period last year [1] Group 1 - The demand in the downstream industry where the company operates is insufficient, leading to increased sales expenses to maintain existing customers and promote new products [1] - The company has experienced a decrease in financial investment income and interest income during the reporting period [1] - Losses have been incurred due to changes in the fair value of trading financial assets [1] Group 2 - The subsidiary has recognized asset impairment losses, and the parent company has incurred losses from the disposal of fixed assets [1]
溢多利(300381) - 2025 Q4 - 年度业绩预告
2026-01-28 11:05
Financial Performance - The company expects a net profit of approximately -26 million yuan for the year 2025, compared to -13 million yuan in the same period last year[4] - The net profit after deducting non-recurring gains and losses is projected to be around -20 million yuan, down from -10 million yuan year-on-year[4] - The decrease in performance is attributed to insufficient demand in the downstream industry, leading to increased sales expenses to maintain existing customers and promote new products[6] Financial Impact Factors - Financial income and interest revenue have decreased, with losses arising from changes in the fair value of trading financial assets[6] - The company anticipates a negative impact of approximately -4 million yuan from non-recurring gains and losses on the net profit attributable to shareholders, primarily due to government subsidies, fixed asset write-off losses, and changes in the fair value of trading financial assets[7] Reporting and Audit Status - The financial data presented is preliminary and has not been audited, with detailed financial information to be disclosed in the 2025 annual report[8]
溢多利:公司R-PET酶目前已完成菌株构建及小试中试,正按计划推进并持续进行重组菌株和酶的性能优化
Mei Ri Jing Ji Xin Wen· 2026-01-23 07:39
Group 1 - The company has made progress on its R-PET enzyme project, completing strain construction and small-scale testing, and is optimizing the performance of recombinant strains and enzymes as planned [2] - The R-PET enzyme is intended for the biological degradation of waste plastics and fabrics, allowing for their recycling as regenerated materials, which can significantly reduce plastic pollution and carbon footprint [2] - The market outlook for the R-PET enzyme is promising, especially in the context of carbon neutrality goals [2]
溢多利(300381.SZ):公司R-PET酶目前已完成菌株构建及小试中试
Ge Long Hui· 2026-01-23 00:57
Core Viewpoint - The company Yiduoli (300381.SZ) is advancing its R-PET enzyme project, which aims to biologically degrade waste plastics and fabrics, thereby significantly reducing plastic pollution and carbon footprint in line with carbon neutrality goals [1] Group 1 - The R-PET enzyme has completed strain construction and small-scale testing, and is progressing according to the established plan [1] - The company is continuously optimizing the performance of recombinant strains and enzymes while exploring pre-treatment and degradation processes for waste plastics [1] - The product is expected to have a strong market outlook due to its potential to recycle waste materials into regenerated resources [1]
溢多利跌2.13%,成交额2969.96万元,主力资金净流出377.27万元
Xin Lang Cai Jing· 2026-01-16 02:37
Core Viewpoint - Yidoli's stock price has shown fluctuations with a recent decline, while the company has experienced mixed financial performance in terms of revenue and net profit [1][2]. Group 1: Stock Performance - As of January 16, Yidoli's stock price decreased by 2.13%, trading at 6.89 CNY per share with a total market capitalization of 3.383 billion CNY [1]. - Year-to-date, Yidoli's stock has increased by 5.67%, with a 1.62% rise over the last five trading days and an 8.85% increase over the last 20 days, while it has seen a slight decline of 0.72% over the past 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Yidoli reported a revenue of 613 million CNY, reflecting a year-on-year growth of 0.77%, while the net profit attributable to shareholders was 18.204 million CNY, which represents a significant decrease of 57.47% compared to the previous year [2]. - Since its A-share listing, Yidoli has distributed a total of 359 million CNY in dividends, with 125 million CNY distributed over the last three years [3]. Group 3: Company Overview - Yidoli, established on September 3, 1991, and listed on January 28, 2014, is located in Zhuhai, Guangdong Province, and specializes in the research, production, and sales of biological enzyme preparations, steroid hormone raw materials, plant extracts, and animal nutrition products [2]. - The company's main business revenue composition includes biological enzyme preparations (83.94%), plant extracts (8.34%), feed and feed additives (6.78%), and other products (0.95%) [2]. - Yidoli is classified under the pharmaceutical and biological industry, specifically in the chemical pharmaceutical and raw material drug sectors, and is associated with concepts such as raw materials, vitamins, small-cap stocks, biological manufacturing, and synthetic biology [2].